Literature DB >> 17889779

Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey.

David F Chang1, Rosa Braga-Mele, Nick Mamalis, Samuel Masket, Kevin M Miller, Louis D Nichamin, Richard B Packard, Mark Packer.   

Abstract

An online survey of members of the American Society of Cataract and Refractive Surgery indicated a strong preference for preoperative and postoperative topical antibiotic prophylaxis, with most surgeons favoring latest generation topical fluoroquinolones. A significant percentage of surgeons reported being concerned about the risks of homemade intracameral antibiotic preparations, and there was a strong desire to have a commercially available antibiotic approved for intracameral injection. This is reflected in the fact that 77% of respondents were still not injecting intracameral antibiotics, but 82% would likely do so if a reasonably priced commercial preparation were available.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889779     DOI: 10.1016/j.jcrs.2007.07.009

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  43 in total

1.  Pharmacokinetics of subconjunctival injection of moxifloxacin in humans.

Authors:  Kazuki Matsuura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-03       Impact factor: 3.117

2.  Evaluation of macular thickness changes after intracameral vancomycin in cataract surgery.

Authors:  Jose L Pérez-Canales; Juan J Pérez-Santonja; Ezequiel Campos-Mollo
Journal:  Int Ophthalmol       Date:  2014-11-12       Impact factor: 2.031

3.  Survey of practice preference pattern in antibiotic prophylaxis against endophthalmitis after cataract surgery in Singapore.

Authors:  Daphne C Y Han; Soon-Phaik Chee
Journal:  Int Ophthalmol       Date:  2012-02-24       Impact factor: 2.031

4.  Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study.

Authors:  Kian Eftekhari; Devon H Ghodasra; Kevin Haynes; Jinbo Chen; John H Kempen; Brian L VanderBeek
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-04-22       Impact factor: 2.890

5.  Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures.

Authors:  Robert E Fintelmann; Eliza N Hoskins; Thomas M Lietman; Jeremy D Keenan; Bruce D Gaynor; Vicky Cevallos; Nisha R Acharya
Journal:  Arch Ophthalmol       Date:  2011-04

6.  Effects of moxifloxacin exposure on the conjunctival flora and antibiotic resistance profile following repeated intravitreal injections.

Authors:  Mustafa Ataş; Burhan Başkan; Ayşe Ozköse; Fatma Mutlu Sarıgüzel; Süleyman Demircan; Emine Pangal
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

7.  Characterization of ocular methicillin-resistant Staphylococcus epidermidis isolates belonging predominantly to clonal complex 2 subcluster II.

Authors:  Paulo J M Bispo; Ana Luisa Hofling-Lima; Antonio C C Pignatari
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

8.  Intracameral Antibiotics in the Shadow of Hemorrhagic Occlusive Retinal Vasculitis.

Authors:  Ayman Naseri; Ronald B Melles; Neal H Shorstein
Journal:  Ophthalmology       Date:  2017-05       Impact factor: 12.079

9.  Intracameral vancomycin following cataract surgery: An eleven-year study.

Authors:  Deepa R Anijeet; Prasad Palimar; Clive O Peckar
Journal:  Clin Ophthalmol       Date:  2010-04-26

10.  MRSA and cataract surgery - reflections for practice.

Authors:  L F Porter; R U Khan; A Hannan; S P Kelly
Journal:  Clin Ophthalmol       Date:  2010-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.